Emcure Pharmaceuticals Limited has filed its draft IPO (Initial Public Offering) papers with capital markets regulator SEBI. The company is looking to raise more than Rs 1,100 crore through the public issue which will include a fresh issue of equity shares upto Rs 1,100 crore and an offer for sale (OFS) of 18,168,356 equity shares by existing shareholders, including promoters of the company. Overall the issue size would be higher than Rs 1,100 crore. In terms of sales, Emcure Pharmaceuticals is the 12th largest pharmaceutical company in India. The company is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products across several geographies and has a presence in 70 markets globally.
Emcure